Medgene Labs
PrivateLast Round
Grant
Sep 1, 2024
Total Funding Raised
$1.2M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Medgene Labs operates in Healthcare & Life Sciences and is based in Brookings, South Dakota. Its latest recorded funding round was a Grant round in September 2024.
Medgene Labs is an animal health company that develops and manufactures innovative veterinary vaccines using a proprietary platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medgene Labs Comparables
Compare Medgene Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cambridge Technologies | 85% | |
| Vacci-Vet Inc. | 82% | |
| SAN Group | 81% |
For institutional investors. Book with your work email.
Medgene Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2024 | ||||
| Grant | May 23, 2023 | ||||
| Seed | Sep 30, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medgene Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Food and Agriculture | Grant |
| U.S. Department of Agriculture | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 28, 31% of headcount.
- Jun 20, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 14, 2026
As of Oct 14th '26, Medgene and the Foundation for Food & Agriculture Research invest $499,996 to develop and test a vaccine designed to protect cattle from New World screwworm, with cattle vaccinations underway to assess safety and immune response before potential field studies.
- is_developingOct 14, 2026
On Oct 14th '26, Medgene is developing the vaccine with FFAR funding to trigger antibodies in cattle that interfere with NWS larvae feeding and development; researchers are assessing safety and immune responses to determine whether it advances to field studies.
- partners_withOct 14, 2026
Medgene partners with FFAR Fellows on research that uses a scalable vaccine platform to target New World screwworm larvae proteins and assess vaccine safety for United States livestock.
- launchesSep 24, 2026
On Sep 24th '26, Medgene rolls out the first platform vaccine targeting Theileria for beef and dairy cattle in South Dakota.
For institutional investors. Book with your work email.
Medgene Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medgene Labs's valuation, stock price, and market status.
Is Medgene Labs a public or private company?
Medgene Labs is a private company.
What is the current stock price of Medgene Labs?
Medgene Labs is a private company, so its shares have no public market price. Caplight tracks Medgene Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medgene Labs worth (valuation)?
Valuation information for Medgene Labs is not publicly available.
Can I buy Medgene Labs stock?
Medgene Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medgene Labs's last funding round?
Medgene Labs's most recent funding round was Grant on September 1, 2024.
Who are the main investors in Medgene Labs?
Key investors in Medgene Labs include National Institute of Food and Agriculture, U.S. Department of Agriculture.
Will Medgene Labs IPO soon?
No public IPO plans have been announced for Medgene Labs.
How can I track Medgene Labs secondary market activity?
Caplight tracks bids, offers, and trades in Medgene Labs's shares on secondary markets.